Nuove frontiere nel trattamento del tumore a cellule giganti dell’osso View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2011-10

AUTHORS

V. Ippolito, S. Ferrari, V. Ferraresi, E. Palmerini, C. Zoccali, R. Biagini

ABSTRACT

Giant cell tumor (GCT) of bone is an aggressive neoplasm arising from the medullary and consisting of multinucleated osteoclast-like giant cells and proliferating osteoblast-like stromal cells. It is a rare neoplasm that accounts for approximately 5% of all primary bone tumors in adults, with an incidence of 1 case per million, and is slightly more prevalent in women than in men; it occurs most frequently at the end of long bones, but every bone can be affected.Curettage is the gold standard treatment, but unfortunately sometimes it is impossible because of lack of structural integrity of the segment, or the presence of a fracture or of a local relapse that is difficult to treat surgically. The use of local adjuvant treatment, as phenol or liquid nitrogen, is suggested to decrease the risk of recurrence. In selected cases resection and reconstruction with a prosthesis are recommended to decrease the risk of recurrence. Radiofrequency thermoablation and cryosurgery with probes should be used in the miniinvasive treatment of small lesions or in case of a local and difficult to treat recurrence. Anyway, a medical approach is the great news in the treatment of GCT. Denosumab is a fully human monoclonal antibody that inhibits RANKL, a protein essential for osteoclast formation, function, and survival. Good clinical, radiological and histological results have been reported in the treatment of GTC of bone with denosumab, but more studies are needed to assess its efficacy and side effects. More... »

PAGES

222-226

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s11639-011-0125-3

DOI

http://dx.doi.org/10.1007/s11639-011-0125-3

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1029318986


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Centro di Oncologia Ortopedica, Spedali Civili, Brescia, Italy", 
          "id": "http://www.grid.ac/institutes/grid.412725.7", 
          "name": [
            "Centro di Oncologia Ortopedica, Spedali Civili, Brescia, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ippolito", 
        "givenName": "V.", 
        "id": "sg:person.01314103534.02", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01314103534.02"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Sezione di Chemioterapia, Istituto Ortopedico Rizzoli, Bologna, Italy", 
          "id": "http://www.grid.ac/institutes/grid.419038.7", 
          "name": [
            "Sezione di Chemioterapia, Istituto Ortopedico Rizzoli, Bologna, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ferrari", 
        "givenName": "S.", 
        "id": "sg:person.013005321532.44", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013005321532.44"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "S.C. Oncologia Medica A, Istituto Nazionale Tumori Regina Elena, Roma, Italy", 
          "id": "http://www.grid.ac/institutes/grid.417520.5", 
          "name": [
            "S.C. Oncologia Medica A, Istituto Nazionale Tumori Regina Elena, Roma, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ferraresi", 
        "givenName": "V.", 
        "id": "sg:person.0624523022.47", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0624523022.47"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Sezione di Chemioterapia, Istituto Ortopedico Rizzoli, Bologna, Italy", 
          "id": "http://www.grid.ac/institutes/grid.419038.7", 
          "name": [
            "Sezione di Chemioterapia, Istituto Ortopedico Rizzoli, Bologna, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Palmerini", 
        "givenName": "E.", 
        "id": "sg:person.01210215667.35", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01210215667.35"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "S.C. Ortopedia Oncologica, Istituto Nazionale Tumori Regina Elena, Roma, Italy", 
          "id": "http://www.grid.ac/institutes/grid.417520.5", 
          "name": [
            "S.C. Ortopedia Oncologica, Istituto Nazionale Tumori Regina Elena, Roma, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Zoccali", 
        "givenName": "C.", 
        "id": "sg:person.01064010161.03", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01064010161.03"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "S.C. Ortopedia Oncologica, Istituto Nazionale Tumori Regina Elena, Roma, Italy", 
          "id": "http://www.grid.ac/institutes/grid.417520.5", 
          "name": [
            "S.C. Ortopedia Oncologica, Istituto Nazionale Tumori Regina Elena, Roma, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Biagini", 
        "givenName": "R.", 
        "id": "sg:person.0673007342.48", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0673007342.48"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s00264-006-0215-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043295496", 
          "https://doi.org/10.1007/s00264-006-0215-7"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00197071", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051262855", 
          "https://doi.org/10.1007/bf00197071"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/978-3-7091-3846-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044182599", 
          "https://doi.org/10.1007/978-3-7091-3846-5"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2011-10", 
    "datePublishedReg": "2011-10-01", 
    "description": "Giant cell tumor (GCT) of bone is an aggressive neoplasm arising from the medullary and consisting of multinucleated osteoclast-like giant cells and proliferating osteoblast-like stromal cells. It is a rare neoplasm that accounts for approximately 5% of all primary bone tumors in adults, with an incidence of 1 case per million, and is slightly more prevalent in women than in men; it occurs most frequently at the end of long bones, but every bone can be affected.Curettage is the gold standard treatment, but unfortunately sometimes it is impossible because of lack of structural integrity of the segment, or the presence of a fracture or of a local relapse that is difficult to treat surgically. The use of local adjuvant treatment, as phenol or liquid nitrogen, is suggested to decrease the risk of recurrence. In selected cases resection and reconstruction with a prosthesis are recommended to decrease the risk of recurrence. Radiofrequency thermoablation and cryosurgery with probes should be used in the miniinvasive treatment of small lesions or in case of a local and difficult to treat recurrence. Anyway, a medical approach is the great news in the treatment of GCT. Denosumab is a fully human monoclonal antibody that inhibits RANKL, a protein essential for osteoclast formation, function, and survival. Good clinical, radiological and histological results have been reported in the treatment of GTC of bone with denosumab, but more studies are needed to assess its efficacy and side effects.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s11639-011-0125-3", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1121576", 
        "issn": [
          "0390-5276", 
          "1970-6812"
        ], 
        "name": "LO SCALPELLO-OTODI Educational", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "3", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "25"
      }
    ], 
    "keywords": [
      "giant cell tumor", 
      "risk of recurrence", 
      "treatment of GCT", 
      "osteoclast-like giant cells", 
      "local adjuvant treatment", 
      "primary bone tumors", 
      "gold standard treatment", 
      "human monoclonal antibody", 
      "radiofrequency thermoablation", 
      "local relapse", 
      "adjuvant treatment", 
      "cases resection", 
      "aggressive neoplasm", 
      "rare neoplasm", 
      "standard treatment", 
      "cell tumors", 
      "bone tumors", 
      "osteoclast formation", 
      "side effects", 
      "miniinvasive treatment", 
      "histological results", 
      "giant cells", 
      "small lesions", 
      "stromal cells", 
      "medical approach", 
      "recurrence", 
      "monoclonal antibodies", 
      "like stromal cells", 
      "long bones", 
      "denosumab", 
      "more studies", 
      "treatment", 
      "neoplasms", 
      "bone", 
      "tumors", 
      "Nuove frontiere", 
      "risk", 
      "curettage", 
      "cells", 
      "resection", 
      "relapse", 
      "lesions", 
      "RANKL", 
      "incidence", 
      "tumores", 
      "thermoablation", 
      "cryosurgery", 
      "antibodies", 
      "women", 
      "efficacy", 
      "survival", 
      "adults", 
      "prosthesis", 
      "men", 
      "cases", 
      "Frontieres", 
      "fractures", 
      "protein essential", 
      "cellules", 
      "study", 
      "lack", 
      "effect", 
      "presence", 
      "segments", 
      "use", 
      "reconstruction", 
      "liquid nitrogen", 
      "function", 
      "structural integrity", 
      "integrity", 
      "GTC", 
      "essential", 
      "end", 
      "results", 
      "probe", 
      "formation", 
      "great news", 
      "approach", 
      "consisting", 
      "news", 
      "phenol", 
      "nitrogen"
    ], 
    "name": "Nuove frontiere nel trattamento del tumore a cellule giganti dell\u2019osso", 
    "pagination": "222-226", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1029318986"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s11639-011-0125-3"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s11639-011-0125-3", 
      "https://app.dimensions.ai/details/publication/pub.1029318986"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-09-02T15:55", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220902/entities/gbq_results/article/article_556.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s11639-011-0125-3"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s11639-011-0125-3'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s11639-011-0125-3'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s11639-011-0125-3'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s11639-011-0125-3'


 

This table displays all metadata directly associated to this object as RDF triples.

194 TRIPLES      21 PREDICATES      110 URIs      99 LITERALS      6 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s11639-011-0125-3 schema:about anzsrc-for:11
2 anzsrc-for:1103
3 schema:author Nb2b3d2f399824b5dae7fbf333d85a7a8
4 schema:citation sg:pub.10.1007/978-3-7091-3846-5
5 sg:pub.10.1007/bf00197071
6 sg:pub.10.1007/s00264-006-0215-7
7 schema:datePublished 2011-10
8 schema:datePublishedReg 2011-10-01
9 schema:description Giant cell tumor (GCT) of bone is an aggressive neoplasm arising from the medullary and consisting of multinucleated osteoclast-like giant cells and proliferating osteoblast-like stromal cells. It is a rare neoplasm that accounts for approximately 5% of all primary bone tumors in adults, with an incidence of 1 case per million, and is slightly more prevalent in women than in men; it occurs most frequently at the end of long bones, but every bone can be affected.Curettage is the gold standard treatment, but unfortunately sometimes it is impossible because of lack of structural integrity of the segment, or the presence of a fracture or of a local relapse that is difficult to treat surgically. The use of local adjuvant treatment, as phenol or liquid nitrogen, is suggested to decrease the risk of recurrence. In selected cases resection and reconstruction with a prosthesis are recommended to decrease the risk of recurrence. Radiofrequency thermoablation and cryosurgery with probes should be used in the miniinvasive treatment of small lesions or in case of a local and difficult to treat recurrence. Anyway, a medical approach is the great news in the treatment of GCT. Denosumab is a fully human monoclonal antibody that inhibits RANKL, a protein essential for osteoclast formation, function, and survival. Good clinical, radiological and histological results have been reported in the treatment of GTC of bone with denosumab, but more studies are needed to assess its efficacy and side effects.
10 schema:genre article
11 schema:isAccessibleForFree false
12 schema:isPartOf N63b14276403c40b78961f4a164826c04
13 N9ffb4b37319046bb86b28cf7082403df
14 sg:journal.1121576
15 schema:keywords Frontieres
16 GTC
17 Nuove frontiere
18 RANKL
19 adjuvant treatment
20 adults
21 aggressive neoplasm
22 antibodies
23 approach
24 bone
25 bone tumors
26 cases
27 cases resection
28 cell tumors
29 cells
30 cellules
31 consisting
32 cryosurgery
33 curettage
34 denosumab
35 effect
36 efficacy
37 end
38 essential
39 formation
40 fractures
41 function
42 giant cell tumor
43 giant cells
44 gold standard treatment
45 great news
46 histological results
47 human monoclonal antibody
48 incidence
49 integrity
50 lack
51 lesions
52 like stromal cells
53 liquid nitrogen
54 local adjuvant treatment
55 local relapse
56 long bones
57 medical approach
58 men
59 miniinvasive treatment
60 monoclonal antibodies
61 more studies
62 neoplasms
63 news
64 nitrogen
65 osteoclast formation
66 osteoclast-like giant cells
67 phenol
68 presence
69 primary bone tumors
70 probe
71 prosthesis
72 protein essential
73 radiofrequency thermoablation
74 rare neoplasm
75 reconstruction
76 recurrence
77 relapse
78 resection
79 results
80 risk
81 risk of recurrence
82 segments
83 side effects
84 small lesions
85 standard treatment
86 stromal cells
87 structural integrity
88 study
89 survival
90 thermoablation
91 treatment
92 treatment of GCT
93 tumores
94 tumors
95 use
96 women
97 schema:name Nuove frontiere nel trattamento del tumore a cellule giganti dell’osso
98 schema:pagination 222-226
99 schema:productId N43d80d8f752c491aa4e2def89e1f0a11
100 N7c047590c66e4aacbbe2ee8544e532bf
101 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029318986
102 https://doi.org/10.1007/s11639-011-0125-3
103 schema:sdDatePublished 2022-09-02T15:55
104 schema:sdLicense https://scigraph.springernature.com/explorer/license/
105 schema:sdPublisher Nae646f8c2e014dc5b3a2c618513e64cc
106 schema:url https://doi.org/10.1007/s11639-011-0125-3
107 sgo:license sg:explorer/license/
108 sgo:sdDataset articles
109 rdf:type schema:ScholarlyArticle
110 N43d80d8f752c491aa4e2def89e1f0a11 schema:name doi
111 schema:value 10.1007/s11639-011-0125-3
112 rdf:type schema:PropertyValue
113 N5b13bf3cd51640f3a6cb7077baf4e9a3 rdf:first sg:person.013005321532.44
114 rdf:rest Ne31449d873ac40419ba788b7b2b389e8
115 N63b14276403c40b78961f4a164826c04 schema:volumeNumber 25
116 rdf:type schema:PublicationVolume
117 N742eaa9d6c824766abca5c695ed73249 rdf:first sg:person.01210215667.35
118 rdf:rest N885f04297d884af2800bcad251774236
119 N7c047590c66e4aacbbe2ee8544e532bf schema:name dimensions_id
120 schema:value pub.1029318986
121 rdf:type schema:PropertyValue
122 N885f04297d884af2800bcad251774236 rdf:first sg:person.01064010161.03
123 rdf:rest N92227357be484793918a160bda873509
124 N92227357be484793918a160bda873509 rdf:first sg:person.0673007342.48
125 rdf:rest rdf:nil
126 N9ffb4b37319046bb86b28cf7082403df schema:issueNumber 3
127 rdf:type schema:PublicationIssue
128 Nae646f8c2e014dc5b3a2c618513e64cc schema:name Springer Nature - SN SciGraph project
129 rdf:type schema:Organization
130 Nb2b3d2f399824b5dae7fbf333d85a7a8 rdf:first sg:person.01314103534.02
131 rdf:rest N5b13bf3cd51640f3a6cb7077baf4e9a3
132 Ne31449d873ac40419ba788b7b2b389e8 rdf:first sg:person.0624523022.47
133 rdf:rest N742eaa9d6c824766abca5c695ed73249
134 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
135 schema:name Medical and Health Sciences
136 rdf:type schema:DefinedTerm
137 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
138 schema:name Clinical Sciences
139 rdf:type schema:DefinedTerm
140 sg:journal.1121576 schema:issn 0390-5276
141 1970-6812
142 schema:name LO SCALPELLO-OTODI Educational
143 schema:publisher Springer Nature
144 rdf:type schema:Periodical
145 sg:person.01064010161.03 schema:affiliation grid-institutes:grid.417520.5
146 schema:familyName Zoccali
147 schema:givenName C.
148 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01064010161.03
149 rdf:type schema:Person
150 sg:person.01210215667.35 schema:affiliation grid-institutes:grid.419038.7
151 schema:familyName Palmerini
152 schema:givenName E.
153 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01210215667.35
154 rdf:type schema:Person
155 sg:person.013005321532.44 schema:affiliation grid-institutes:grid.419038.7
156 schema:familyName Ferrari
157 schema:givenName S.
158 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013005321532.44
159 rdf:type schema:Person
160 sg:person.01314103534.02 schema:affiliation grid-institutes:grid.412725.7
161 schema:familyName Ippolito
162 schema:givenName V.
163 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01314103534.02
164 rdf:type schema:Person
165 sg:person.0624523022.47 schema:affiliation grid-institutes:grid.417520.5
166 schema:familyName Ferraresi
167 schema:givenName V.
168 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0624523022.47
169 rdf:type schema:Person
170 sg:person.0673007342.48 schema:affiliation grid-institutes:grid.417520.5
171 schema:familyName Biagini
172 schema:givenName R.
173 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0673007342.48
174 rdf:type schema:Person
175 sg:pub.10.1007/978-3-7091-3846-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044182599
176 https://doi.org/10.1007/978-3-7091-3846-5
177 rdf:type schema:CreativeWork
178 sg:pub.10.1007/bf00197071 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051262855
179 https://doi.org/10.1007/bf00197071
180 rdf:type schema:CreativeWork
181 sg:pub.10.1007/s00264-006-0215-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043295496
182 https://doi.org/10.1007/s00264-006-0215-7
183 rdf:type schema:CreativeWork
184 grid-institutes:grid.412725.7 schema:alternateName Centro di Oncologia Ortopedica, Spedali Civili, Brescia, Italy
185 schema:name Centro di Oncologia Ortopedica, Spedali Civili, Brescia, Italy
186 rdf:type schema:Organization
187 grid-institutes:grid.417520.5 schema:alternateName S.C. Oncologia Medica A, Istituto Nazionale Tumori Regina Elena, Roma, Italy
188 S.C. Ortopedia Oncologica, Istituto Nazionale Tumori Regina Elena, Roma, Italy
189 schema:name S.C. Oncologia Medica A, Istituto Nazionale Tumori Regina Elena, Roma, Italy
190 S.C. Ortopedia Oncologica, Istituto Nazionale Tumori Regina Elena, Roma, Italy
191 rdf:type schema:Organization
192 grid-institutes:grid.419038.7 schema:alternateName Sezione di Chemioterapia, Istituto Ortopedico Rizzoli, Bologna, Italy
193 schema:name Sezione di Chemioterapia, Istituto Ortopedico Rizzoli, Bologna, Italy
194 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...